Your session is about to expire
← Back to Search
Beta-Agonists vs Botox for Urinary Incontinence (BEST Trial)
BEST Trial Summary
This trial will compare two treatments for women with UUI: an oral medication or injections. Patients will be followed for 12 months to measure satisfaction & symptom severity.
BEST Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowBEST Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.BEST Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am not on anticholinergics or can stop them for 3 weeks before joining.My main issue is urge incontinence, not stress incontinence, which has been stable for over 3 months and I don't seek treatment for stress incontinence soon.I have had pelvic floor surgery in the last 3 months.I am quite bothered by sudden urges to urinate leading to urine loss.I have ongoing urinary incontinence despite trying basic treatments or can't take certain medications due to side effects or other reasons.I have a condition where my bladder doesn't empty properly.I cannot take certain medications due to my health condition.I expect to have pelvic surgery within the next 3 months.I am 18 years old or older.I tried a neuromodulation treatment that didn't work and waited 4 weeks.I have had radiation therapy to my pelvic area before.I have blood in my urine or a history of bladder cancer.You had a significant amount of urine left in your bladder after going to the bathroom in the past 3 months.I have had surgery on the muscle that controls my bladder.
- Group 1: Beta-3 receptor agonist oral medication
- Group 2: Intradetrusor onabotulinumtoxinA
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the FDA granted its stamp of approval for Beta-3 receptor agonist oral medication?
"This Beta-3 receptor agonist oral medication has been approved, so it is given a score of 3 for its safety."
How many sites are actively managing this research project?
"The research is recruiting patients at the University of California, San Diego (San Diego, CA), Howard University (Washington D.C.) and the University of New mexico (Albuquerque, NM) in addition to 5 more sites."
Is enrollment in this research endeavor currently available to participants?
"Clinicaltrials.gov's records indicate that this experiment is not currently accepting patients, as the most recent update was on March 28th of 2023. Although no longer recruiting for participants, there are still 150 other trials searching for volunteers at this time."
Share this study with friends
Copy Link
Messenger